TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biobact AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
168 |
| Financial expenses |
1
|
7
|
52 |
| Earnings before taxes |
38
|
-81
|
3,244 |
| EBITDA |
-96
|
-124
|
-962 |
| Total assets |
744
|
2,409
|
3,776 |
| Current assets |
561
|
1,470
|
3,776 |
| Current liabilities |
554
|
36
|
1,335 |
| Equity capital |
190
|
2,374
|
2,441 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
25.5%
|
98.5%
|
64.6% |
| Turnover per employee |
0
|
0
|
84 |
| Profit as a percentage of turnover | 1931.0% | ||
| Return on assets (ROA) |
5.2%
|
-3.1%
|
87.3% |
| Current ratio |
101.3%
|
4083.3%
|
282.8% |
| Return on equity (ROE) |
20.0%
|
-3.4%
|
132.9% |
| Change turnover |
0
|
-169
|
-687 |
| Change turnover % |
-100%
|
-80% | |
| Chg. No. of employees |
0
|
-1
|
-2 |
| Chg. No. of employees % |
0%
|
-50%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.